Basic transport phenomena in biomedical engineering, third edition

Basic Transport Phenomena in Biomedical Engineering, Third Edition

Volumn , Issue , 2011, Pages 1-451

  Fournier, Ronald L ^a  

^a UNIVERSITY OF TOLEDO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85059709546     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Book

References (354)

1. Abbas, M. and V.P. Tyagi. 1987. Analysis of a hollow fiber artificial kidney performing simultaneous dialysis and ultrafiltration. Chem. Eng. Sci. 42:133-42.
2. Agrawal, C.M., G.G. Niederauer, and K.A. Athanasiou. 1995. Fabrication and characterization of PLA-PGA orthopedic implants. Tiss. Eng. 1:241-52.
3. Alberts, B., D. Bray, J. Lewis, M. Raff, K. Roberts, and J.D. Watson. 1989. Molecular Biology of the Cell. 2nd ed. New York: Garland Publishing.
4. Al-Hendy, A., G. Hortelano, G.S. Tannenbaum, and P.L. Chang. 1995. Correction of the growth defect in dwarf mice with nonautologous microencapsulated myoblasts-an alternate approach to somatic gene therapy. Hum. Gene Ther. 6:165-75.
5. Allen, J.W. and S.N. Bhatia. 2003. Formation of steady state oxygen gradients in vitro: Application to liver zonation. Biotechnol. Bioeng. 82:253-62.
6. Allen, J.W., T. Hassanein, and S.N. Bhatia. 2001. Advances in bioartificial liver devices. Hepatology 34:447-55.
7. Altman, J.J., D. Houlbert, P. Callard, P. McMillan, B.A. Solomon, J. Rosen, and P.M. Galletti. 1986. Longterm plasma glucose normalization in experimental diabetic rats with microencapsulated implants of benign human insulinomas. Diabetes 35:625-33.
8. Ameer, G.A., W. Harmon, R. Sasisekharan, and R. Langer. 1999a. Investigation of a whole blood fluidized bed Taylor-Couette flow device for enzymatic heparin neutralization. Biotechnol. Bioeng. 62:602-8.
9. Ameer, G.A., S. Raghavan, R. Sasisekharan, W. Harmon, C.L. Cooney, and R. Langer. 1999b. Regional heparinization via simultaneous separation and reaction in a novel Taylor-Couette flow device. Biotechnol. Bioeng. 63:618-24.
10. American Diabetes Association. 1993. Position statement. Implications of the diabetes control and complications trial. Diabetes 42:1555-58.
11. Anderson, J.L. and J.A. Quinn. 1974. Restricted transport in small pores. Biophys. J. 14:130-49.
12. Anderson, J.M. 1994. The extracellular matrix and biomaterials. In Implantation Biology, ed. R.S. Greco, 113-30. Boca Raton, FL: CRC Press.
13. Armer, T.A. and T.R. Hanley. 1986. Characterization of mass transfer in the hollow fiber artificial kidney. Chem. Eng. Commun. 47:49-71.
14. Arnold, F. and D.C. West. 1991. Angiogenesis in wound healing. Pharmacol. Ther. 52:407-22.
15. Arpaci, V.S. 1966. Conduction Heat Transfer. Reading, MA: Addison-Wesley.
16. Atkinson, M.A. and N.K. Maclaren. 1990. What causes diabetes? Sci. Am. July: 62-71.
17. Baker, A.R., R.L. Fournier, J.G. Sarver, J.L. Long, P.J. Goldblatt, J.M. Horner, and S.H. Selman. 1997.Evaluation of an immunoisolation membrane formed by incorporating a polyvinyl alcohol hydrogel within a microporous filter support. Cell Transplant. 6:585-95.
18. Barbee, J.H. and G.R. Cokelet. 1971a. Prediction of blood flow in tubes with diameters as small as 29μ. Microvasc. Res. 3:17-21.
19. Barbee, J.H. and G.R. Cokelet. 1971b. The Fahraeus effect. Microvasc. Res. 3:6-16.
20. Bass, L. and S. Keiding. 1988. Physiologically based models and strategic experiments in hepatic pharmacology. Biochem. Pharmcol. 37:1425-31.
21. Bawa, R., R.A. Siegel, B. Marasca, M. Karel, and R. Langer. 1985. An explanation for the controlled release of macromolecules from polymers. J. Control. Release 1:259-67.
22. Bazilevsky, A.V., K.G. Kornev, A.N. Rozhkov, and A.V. Neimark. 2003. Spontaneous absorption of viscous and viscoelastic fluids by capillaries and porous substrates. J. Coll. Interface Sci. 262:16-24.
23. Beck, R.E. and J.S. Schultz. 1970. Hindered diffusion in microporous membranes with known pore geometry. Science 170:1302-5.
24. Benjamin, E. and S. Leskowitz. 1991. Immunology: A Short Course. New York: Wiley-Liss.
25. Berger, M. and D. Rodbard. 1989. Computer simulation of plasma and glucose dynamics after subcutaneous insulin injection. Diabetes Care 12:725-36.
26. Bernstein, H., V.C. Yang, and R. Langer. 1987a. Distribution of heparinase covalently immobilized to agarose: Experimental and theoretical studies. Biotechnol. Bioeng. 30:196-207.
27. Bernstein, H., V.C. Yang, and R. Langer. 1987b. Immobilized heparinase: In vitro reactor model. Biotechnol. Bioeng. 30:239-50.
28. Bird, R.B., W.E. Stewart, and E.N. Lightfoot. 2002. Transport Phenomena. 2nd ed. New York: John Wiley.
29. Braasch, D., and W. Jenett. 1968. Erythrocytenflexibilität, Hämokonzentration und Reibungswiderstand in Glascapillaren mit Durchmessern zwischen 6 bis 50 microns. Pflugers Arch. 302, 245-254.
30. Brinkman, H.C. 1947. A calculation of the viscous force exerted by a flowing fluid on a dense swarm of particles. Appl. Sci. Res. A1:27-34.
31. Brown, A.N., B-S. Kim, E. Alsberg, and D.J. Mooney. 2000. Combining chondrocytes and smooth muscle cells to engineer hybrid soft tissue constructs. Tiss. Eng. 6:297-305.
32. Bungay, P.M. and H. Brenner. 1973. The motion of a closely fitting sphere in a fluid filled tube. Int. J. Multiph. Flow. 1:25.
33. Burton, A.C. 1972. Physiology and Biophysics of the Circulation. 2nd ed. Chicago: Year Book Medical Publishers.
34. Bush, M.B., P.E. Papa Petros, and B.R. Barrett-Lennard. 1997. On the flow through the human urethra. J. Biomech. 30: 967-969.
35. Cai, Z., Z. Shi, G.M. O’Shea, and A.M. Sun. 1988. Microencapsulated hepatocytes for bioartificial liver support. Artif. Org. 12:388-93.
36. Caplan, A. 1991. Mesenchymal stem cells. J. Orthopaedic Res. 9:641-50.
37. Cappello, A., F. Grandi, C. Lamberti, and A. Santoro. 1994. Comparative evaluation of different methods to estimate urea distribution volume and generation rate. Int. J. Artif. Org. 17:322-30.
38. Carver, S.E. and C.A. Heath. 1999. Semi-continuous perfusion system for delivering intermittent physiological pressure to regenerating cartilage. Tiss. Eng. 5:1-11.
39. Castro, C.I. and J.C. Briceno. 2010. Perfluorocarbon-based oxygen carriers: Review of products and trials. Artif. Org. 34:622-34.
40. Catapano, G., A. Wodetzki, and U. Baurmeister. 1992. Blood flow outside regularly spaced hollow fibers: The future concept of membrane devices? Int. J. Artif. Org. 15:327-30.
41. Cavallaro, J.F., P.D. Kemp, and K.H. Kraus. 1994. Collagen fabrics as biomaterials. Biotechnol. Bioeng. 43:781-91.
42. Chang, P.L. 1997. Nonautologous gene therapy with implantable devices. IEEE Eng. Med. Biol. September/October: 145-50.
43. Chang, P.L., N. Shen, and A.J. Wescott. 1993. Delivery of recombinant gene products with microencapsulated cells in vivo. Hum. Gene Ther. 4:433-40.
44. Charm, S.E. and G.S. Kurland. 1974. Blood Flow and Microcirculation. New York: John Wiley.
45. Cheng, S-Y., J. Gross, and A. Sambanis. 2004. Hybrid pancreatic tissue substitute consisting of recombinant insulin-secreting cells and glucose responsive material. Biotechnol. Bioeng. 87:863-73.
46. Chick, W.L., J.J. Perna, V. Lauris, D. Low, P.M. Galletti, G. Panol, A.D. Whittemore, A.A. Like, C.K. Colton, and M.J. Lysaght. 1977. Artificial pancreas using living beta cells: Effects on glucose homeostasis in diabetic rats. Science 197:780-82.
47. Cieslinski, D.A. and H.D. Humes. 1994. Tissue engineering of a bioartificial kidney. Biotechnol. Bioeng. 43:678-81.
48. Cima, L.G., D.E. Ingber, J.P. Vacanti, and R. Langer. 1991a. Hepatocyte culture on biodegradable polymeric substrates. Biotechnol. Bioeng. 38:145-58.
49. Cima, L.G., J.P. Vacanti, C. Vacanti, D. Ingber, D. Mooney, and R. Langer. 1991b. Tissue engineering by cell transplantation using degradable polymer substrates. J. Biomech. Eng. 113:143-51.
50. Clark, W.R. and D. Gao. 2002. Properties of membranes used for hemodialysis therapy. Semin. Dial. 15:191-95.
51. Colton, C.K. 1995. Implantable biohybrid artificial organs. Cell Transplant. 4:415-36.
52. Colton, C.K. and E.S. Avgoustiniatos. 1991. Bioengineering in development of the hybrid artificial pancreas. J. Biomech. Eng. 113:152-70.
53. Colton, C.K. and E.G. Lowrie. 1981. Hemodialysis: Physical principles and technical considerations. In The Kidney, ed. B.M. Brenner and F.C. Rector, Jr. 2nd ed., 2425-89, Vol. 2. Philadelphia: W.B. Saunders.
54. Cooney, D.O. 1976. Biomedical Engineering Principles. New York: Marcel Dekker.
55. Curry, F.E. and C.C. Michel. 1980. A fiber matrix model of capillary permeability. Microvasc. Res. 20:96-99.
56. Cussler, E.L. 1984. Diffusion: Mass Transfer in Fluid Systems. Cambridge: Cambridge University Press.
57. Davidson, A.J., M.J. Ellis, and J.B. Chaudhuri. 2010. A theoretical method to improve and optimize the design of bioartificial livers. Biotechnol. Bioeng. 106:980-88.
58. Dee, K.C., D.A. Puleo, and R. Bizios. 2002. Tissue-Biomaterial Interactions. Hoboken, NJ: John Wiley.
59. Deen, W.M. 1987. Hindered transport of large molecules in liquid-filled pores. AIChE J. 33:1409-25.
60. Dionne, K.E., C.K. Colton, and M.L. Yarmush. 1989. Effect of oxygen on isolated pancreatic tissue. ASAIO Trans. 35:739-41.
61. Dionne, K.E., C.K. Colton, and M.L. Yarmush. 1991. A microperfusion system with environmental control for studying insulin secretion by pancreatic tissue. Biotechnol. Prog. 7:359-68.
62. Dionne, K.E., B.M. Cain, R.H. Li, W.J. Bell, E.J. Doherty, D.H. Rein, M.J. Lysaght, and F.T. Gentile. 1996. Transport characterization of membranes for immunoisolation. Biomaterials 17:257-66.
63. Douglas, J.A. and M.V. Sefton. 1990. The permeability of EUDRAGIT RL and HEMA-MMA microcapsules to glucose and inulin. Biotechnol. Bioeng. 36:653-64.
64. Durbin, R.P. 1960. Osmotic flow of water across permeable cellulose membranes. J. Gen. Physiol. 44:315-26.
65. Efrat, S. 1999. Genetically engineered pancreatic beta-cell lines for cell therapy of diabetes. Ann. NY Acad. Sci. 875:286-93.
66. Fissell, W.H., J. Kimball, S.M. Mackay, A. Funke, and H.D. Humes. 2001. The role of a bioengineered kidney in renal failure. Ann. NY Acad. Sci. 944:284-95.
67. Fogler, H.S. 2005. Elements of Chemical Reaction Engineering. 4th ed. New York: Prentice-Hall.
68. Folkman, J. 1985. Tumor angiogenesis. Can. Res. 43:175-203.
69. Folkman, J. and M. Klagsbrun. 1987. Angiogenic factors. Science 235:442-47.
70. Foster, T.H., D.F. Hartley, M.G. Nichols, and R. Hilf. 1993. Fluence rate effects in photodynamic therapy of multicell tumor spheroids. Cancer Res. 53:1249-1254.
71. Freeman, B. 1995. Osmosis. In Encyclopedia of Applied Physics, ed. G.L. Trigg. Vol. 13. Berlin: VCH Publishers.
72. Friedman, D.W., P.J. Orland, and R.S. Greco. 1994. Biomaterials: An historical perspective. In Implantation Biology, ed. R.S. Greco, Chapter 1. Boca Raton, FL: CRC Press.
73. Friedman, E.A. 1989. Toward a hybrid bioartificial pancreas. Diabetes Care 12: 415-19.
74. Fukui, Y., A. Funakubo, and T. Kawamura. 1994. Development of an intra blood circuit membrane oxygenator. ASAIO J. M732-34. 40: M732-734.
75. Fung, Y.C. 1993. Biomechanics: Mechanical Properties of Living Tissues. 2nd ed. New York: Springer-Verlag.
76. Gabriel, J.L., T.F. Miller, M.R. Wolfson, and T.H. Shaffer. 1996. Quantitative structure-activity relationships of perfluorinated hetero-hydrocarbons as a potential respiratory media. ASAIO J. 42:968-73.
77. Gaehtgens, P. 1980. Flow of blood through narrow capillaries: Rheological mechanisms determining capillary hematocrit and apparent viscosity. Biorheology 17:183-89.
78. Galban, C.J. and B.R. Locke. 1997. Analysis of cell growth in a polymer scaffold using a moving boundary approach. Biotechnol. Bioeng. 56:422-32.
79. Galletti, P.M. and C.K. Colton. 1995. Artificial lungs and blood-gas exchange devices. In The Biomedical Engineering Handbook, ed. J.D. Bronzino, 1879-1997. Boca Raton, FL: CRC Press.
80. Galletti, P.M., C.K. Colton, and M.J. Lysaght. 1995. Artificial kidney. In The Biomedical Engineering Handbook, ed. J.D. Bronzino, 1898-1922. Boca Raton, FL: CRC Press.
81. Galletti, P.M. and H.O. Jauregui. 1995. Liver support systems. In The Biomedical Engineering Handbook, ed. J.D. Bronzino, 1952-66. Boca Raton, FL: CRC Press.
82. Garred, L.J., B. Canaud, and P.C. Farrell. 1983. A simple kinetic model for assessing peritoneal mass transfer in chronic ambulatory peritoneal dialysis. ASAIO J. 6:131-37.
83. Gemmiti, C.V. and R.E. Guldberg. 2009. Shear stress magnitude and duration modulates matrix composition and tensile mechanical properties in engineered cartilaginous tissue. Biotechnol. Bioeng. 104:809-20.
84. Gharapetian, H., N.A. Davies, and A.M. Sun. 1986. Encapsulation of viable cells within polyacrylate membranes. Biotechnol. Bioeng. 28:1595-1600.
85. Gharapetian, H., M. Maleki, G.M. O’Shea, R.C. Carpenter, and A.M. Sun. 1987. Polyacrylate microcapsules for cell encapsulation: Effects of copolymer structure on membrane properties. Biotechnol. Bioeng. 29:775-79.
86. Gibaldi, M. and D. Perrier. 1982. Pharmacokinetics. 2nd ed. New York: Marcel Dekker.
87. Gibbon, J.H. 1954. Application of a mechanical heart and lung apparatus to cardiac surgery. Minnesota Med. 37:71.
88. Giorgio, T.D., A.D. Moscioni, J. Rozga, and A.A. Demetriou. 1993. Mass transfer in a hollow fiber device used as a bioartificial liver. ASAIO J. 39:886-92.
89. Goldstein, A.S., G. Zhu, G.E. Morris, R.K. Meszlenyi, and A.G. Mikos. 1999. Effect of osteoblastic culture conditions on the structure of poly(DL-lactic-co-glycolic acid) foam scaffolds. Tiss. Eng. 5:421-32.
90. Goorha, Y.K., P. Deb, T. Chatterjee, P.S. Dhot, and R.S. Prasad. 2003. Artificial blood. Med. J. Armed Forces India 59:45-50.
91. Gray, D.N. 1981. The status of olefin-SO2 copolymers as biomaterials. In Biomedical and Dental Applications of Polymers, ed. C.G. Gebelein and F.F. Koblitz, 21-27. New York: Plenum.
92. Gray, D.N. 1984. Polymeric membranes for artificial lungs. ACS Symposium Series No. 256. In Polymer Materials and Artificial Organs, ed. C.G. Gebelein, 151-61. Washington, DC: American Chemical Society.
93. Gray, D.W.R. 2001. An overview of the immune system with specific reference to membrane encapsulation and islet transplantation. Ann. NY Acad. Sci. 944:226-39.
94. Griffith, B.P., R.L. Kormos, H.S. Borovetz, K. Litwak, J.F. Antaki, V.L. Poirier, and K.C. Butler. 2001. HeartMate II left ventricular assist system: From concept to first clinical use. Ann. Thorac. Surg. 71:5116-20.
95. Grodsky, G.M. 1972. A threshold distribution hypothesis for packet storage of insulin and its mathematical modeling. J. Clin. Invest. 51:2047-59.
96. Grundfest-Broniatowski, S.F., G. Tellioglu, K.S. Rosenthal, J. Kang, G. Erdodi, B. Yalcin, M. Cakmak, et al. 2009. A new bioartificial pancreas utilizing amphiphilic membranes for the immunoisolation of porcine islets. ASAIO J. 55:400-5.
97. Gu, Y.J., K. Inoue, S. Shinohara, R. Doi, M. Kogire, T. Aung, S. Sumi, et al. 1994. Xenotransplantation of bioartificial pancreas using a mesh-reinforced polyvinyl alcohol bag. Cell Transplant. 3:S19-S21.
98. Guyton, A.C. 1991. Textbook of Medical Physiology. 8th ed. Philadelphia: W.B. Saunders.
99. Guyton, J.R., R.O. Foster, J.S. Soeldner, M.H. Tan, C.B. Kahn, L. Koncz, and R.E. Gleason. 1978. A model of glucose insulin homeostasis in man that incorporates the heterogeneous fast pool theory of pancreatic insulin release. Diabetes 27:1027-42.
100. Guzman, A.M., R.A. Escobar, and C.H. Amon. 2005. Methodology for predicting oxygen transport on an intravenous membrane oxygenator combining computational and analytical models. J. Biomech. Eng. 127:1127-40.
101. Hachiya, H.L., P.A. Halban, and G.L. King. 1988. Intracellular pathways of insulin transport across vascular endothelial cells. Am. J. Physiol. 255 (Cell Physiol. 24): C459-64.
102. Hacker, M., K. Bachmann, and W. Messer. 2009. Pharmacology: Principles and Practice. Burlington, MA: Academic Press.
103. Hammar, H. 1993.Wound healing. Int. J. Dermatol. 32:6-15.
104. Hantsen, P.D. 1998. Understanding drug-drug interactions. Sci. Med. 5:16-25.
105. Hashimoto, S., M. Honda, M. Yamaguchi, M. Sekimoto, and Y. Tanaka. 1997. Pharmacokinetics of imipenem and cilastatin during continuous venovenous hemodialysis in patients who are critically ill. ASAIO J. 43:84-88.
106. Hayashi, H., K. Inoue, T. Aung, T. Tun, G. Yuanjun, W. Wenjing, S. Shinohara, et al. 1996. Application of a novel B cell line MIN6 to a mesh reinforced polyvinyl alcohol hydrogel tube and three layer agarose microcapsules: An in vitro study. Cell Transplant. 5:S65-S69.
107. Haynes, R.F. 1960. Physical basis of the dependence of blood viscosity on tube radius. Am. J. Physiol. 198:1193.
108. Hewitt, T.J., B.G. Hattler, and W.J. Federspiel. 1998. A mathematical model of gas exchange in an intravenous membrane oxygenator. Ann. Biomed. Eng. 26:166-78.
109. Heywood, H.K., D.L. Bader, and D.A. Lee. 2006. Rate of oxygen consumption by isolated articular chondrocytes is sensitive to medium glucose concentration. J. Cell Physiol. 206 (2): 402-10.
110. Hill, R.S., L.A. Martinson, S.K. Young, and R.W. Dudek. 1994. Macroporous devices for diabetes correction. In Immunoisolation of Pancreatic Islets, ed. R.P. Lanza and W.L. Chick, Chapter 12. Boulder, CO: R.G. Landes.
111. Holder, W.D., H.E. Gruber, W.D. Roland, A.L. Moore, C.R. Culberson, A.B. Loebsack, K.J.L. Burg, and D.J. Mooney. 1997. Increased vascularization and heterogeneity of vascular structures occurring in polyglycolide matrices containing aortic endothelial cells implanted in the rat. Tiss. Eng. 3:149-60.
112. Horwitz, A.E. 1997. Integrins and health. Sci. Am. 276:68-75.
113. Hubbell, J.A. 1997. Matrix effects. In Principles of Tissue Engineering, ed. R.P. Lanza, R. Langer, and W.L. Chick, 247-62. Austin, TX: R.G. Landes.
114. Hughes, M., A. Vassilakos, D.W. Andrews, G. Hortelano, J. Belmont, and P.L. Chang. 1994. Construction of a secretable adenosine deaminase for a novel approach to somatic gene therapy. Hum. Gene Ther. 5:1445-54.
115. Humes, H.D. 1995. Tissue engineering of the kidney. In The Biomedical Engineering Handbook, ed. J.D. Bronzino, 1807-24. Boca Raton, FL: CRC Press.
116. Humes, H.D. 1997. Application of cell and gene therapies in the tissue engineering of renal replacement devices. In Principles of Tissue Engineering, ed. R.P. Lanza, R. Langer, and W.L. Chick, 577-89. Boulder, CO: R.G. Landes.
117. Humes, H.D. and D.A. Cieslinski. 1992. Interaction between growth factors and retinoic acid in the induction of kidney tubulogenesis. Exp. Cell Res. 201:8-15.
118. Humes, H.D., W.F. Weitzel, R.H. Bartlett, F.C. Swaniker, E.P. Paganini, J.R. Luderer, and J. Sobota. 2004. Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failure. Kidney Int. 66:1578-88.
119. Inoue, K., T. Fujisato, Y.J. Gu, K. Burczak, S. Sumi, M. Kogire, T. Tobe, et al. 1992. Experimental hybrid islet transplantation: Application of polyvinyl alcohol membrane for entrapment of islets. Pancreas 7:562-68.
120. Intaglietta, M. 1997. Whitaker Lecture 1996. Microcirculation, biomedical engineering, and artificial blood. Ann. Biomed. Eng. 25:593-603.
121. Intaglietta, M. and R.M. Winslow. 1995. Artificial blood. In The Biomedical Engineering Handbook, ed. J.D. Bronzino, 2011-24. Boca Raton, FL: CRC Press.
122. Ip, T.K. and P. Aebischer. 1989. Renal epithelial-cell-controlled solute transport across permeable membranes as the foundation for a bioartificial kidney. Artif. Org. 13:58-65.
123. Iwata, H., N. Morikawa, and Y. Ikada. 1996. Permeability of filters used for immunoisolation. Tiss. Eng. 2:289-98
124. Jacobs, M.A., R.H. Schreuder, K. Jap-A-Joe, J.J. Nauta, P.M. Andersen, and R.J. Heine. 1993. The pharmacodynamics and activity of intranasally administered insulin in healthy male volunteers. Diabetes. 42:1649-1655.
125. James, K. and J. Kohn. 1996. New biomaterials for tissue engineering. MRS Bull. 21:22-26.
126. Jarvik, R.K. 1981. The total artificial heart. Sci. Am. 244:74-80.
127. Jauregui, H.O., C.J.P. Mullon, and B.A. Solomon. 1997. Extracorporeal artificial liver support. In Principles of Tissue Engineering, ed. R.P. Lanza, R. Langer, and W.L. Chick, 463-79. Austin, TX: R.G. Landes.
128. Johnson, L.B., J. Aiken, D. Mooney, B.L. Schloo, L. Griffith-Cima, R. Langer, and J.P. Vacanti. 1994. The mesentery as a laminated vascular bed for hepatocyte transplantation. Cell Transplant. 3:273-81.
129. Joshi, A. and J. Raje. 2002. Sonicated transdermal drug transport. J. Control. Release 83:13-22.
130. Jurmann, M.J., S. Demertzis, H-J. Schaeffers, T. Wahlers, and A. Haverich. 1992. Intravascular oxygenation for advanced respiratory therapy. ASAIO J. 38:120-24.
131. Karoor, S., J. Molina, C.R. Buchmann, C. Colton, J.S. Logan, and L.W. Henderson. 2003. Immunoaffinity removal of xenoreactive antibodies using modified dialysis or microfiltration membranes. Biotechnol. Bioeng. 81:134-48.
132. Kaufmann, P.M., S. Heimrath, B.S. Kim, and D.J. Mooney. 1997. Highly porous polymer matrices as a three-dimensional culture system for hepatocytes. Cell Transplant. 6:463-68.
133. Kedem, O. and A. Katchalsky. 1958. Thermodynamic analysis of the permeability of biological membranes to nonelectrolytes. Biochem. Biophys. Acta 27: 229.
134. Kelly, J.H. and N.L. Sussman. 1994. The hepatix extracorporeal liver assist device in the treatment of fulminant hepatic failure. ASAIO J. 40:83-85.
135. Kitigawa, T., T. Yamaoka, R. Iwase, and A. Murakami. 2005. Three-dimensional cell seeding and growth in radial-flow perfusion bioreactor for in vitro tissue reconstruction. Biotechnol. Bioeng. 93:947-54.
136. Kobayashi, N., T. Okitsu, S. Nakaji, and N. Tanaka. 2003. Hybrid bioartificial liver: Establishing a reversibly immortalized human hepatocyte line and developing a bioartificial liver for practical use. J. Artif. Org. 6:236-44.
137. Kolff, W.J. 1947. New Ways of Treating Uremia: The Artificial Kidney, Peritoneal Lavage, Intestinal Lavage. London: J.A. Churchill.
138. Koller, M.R. and B.O. Palsson. 1993. Tissue engineering: Reconstitution of human hematopoiesis ex vivo. Biotechnol. Bioeng. 42:909-30.
139. Kornev, K.G. and A.V. Neimark. 2001. Spontaneous penetration of liquids into capillaries and porous membranes revisited. J. Col. Int. Sci. 235:101-13.
140. Koushanpour, E. 1976. Renal Physiology. Philadelphia: W.B. Saunders.
141. Kraegen, E.W., J.D. Young, E.P. George, and L. Lazarus. 1972. Oscillations in blood glucose and insulin after oral glucose. Horm. Met. Res. 4:409-13.
142. Krewson, C.E., M. Klarman, and W.M. Saltzman. 1995. Distribution of nerve growth factor following direct delivery to brain interstitium. Brain Res. 680:196-206.
143. Krogh, A. 1919. The number and distribution of capillaries in muscles with calculations of the oxygen pressure head necessary for supplying the tissue. J. Physiol. 52:409-15.
144. Lacy, P.E. 1995. Treating diabetes with transplanted cells. Sci. Am. 273:501-48.
145. Lacy, P.E., O.D. Hegre, A. Gerasimidi-Vazeou, F.T. Gentile, and K.E. Dionne. 1991. Maintenance of normoglycemia in diabetic mice by subcutaneous xenografts of encapsulated islets. Science 254:1782-84.
146. Lagerlund, T.D. and P.A. Low. 1993. Mathematical modeling of time dependent oxygen transport in rat peripheral nerve. Comput. Biol. Med. 23:29-47.
147. Lakey, J.R.T., R.V. Rajotte, G.L Warnock, and N.M. Kneteman. 1995. Human pancreas preservation prior to islet isolation. Cold ischemic tolerance. Transplantation 59:689-694.
148. Lakey, J.R.T., G.L. Warnock, Z. Ao, and R.V. Rajotte. 1996. Bulk cryopreservation of isolated islets of Langerhans. Cell Transplant. 5:395-404.
149. Langer, R. and J.P. Vacanti. 1993. Tissue engineering. Science 260:920-26.
150. Langer, R., J.P. Vacanti, C.A. Vacanti, A. Atala, L.E. Freed, and G. Vunjak-Novakovic. 1995. Tissue engineering: Biomedical applications. Tiss. Eng. 1:151-61.
151. Lanza, R.P., A.M. Beyer, and W.L. Chick. 1994. Xenogeneic humoral responses to islets transplanted in biohybrid diffusion chambers. Transplantation 57:1371-75.
152. Lanza, R.P., A.M. Beyer, J.E. Staruk, and W.L. Chick. 1993. Biohybrid artificial pancreas. Transplantation 56:1067-72.
153. Lanza, R.P., D.H. Butler, K.M. Borland, J.E. Staruk, D.L. Faustman, B.A. Solomon, T.E. Muller, et al. 1991. Xenotransplantation of canine, bovine, and porcine islets in diabetic rats without immunosuppression. Proc. Natl. Acad. Sci. USA 88:11100-4.
154. Lanza, R.P., D.H. Butler, K.M. Borland, J.M. Harvey, D.L. Faustman, B.A. Solomon, T.E. Muller, et al. 1992a. Successful xenotransplantation of a diffusion based biohybrid artificial pancreas: A study using canine, bovine, and porcine islets. Transplant. Proc. 24:669-71.
155. Lanza, R.P., K.M. Borland, P. Lodge, M. Carretta, S.J. Sullivan, T.E. Muller, B.A. Solomon, T. Maki, A.P. Monaco, and W.L. Chick. 1992c. Treatment of severely diabetic pancreatectomized dogs using a diffusion-based hybrid pancreas. Diabetes 41:886-89.
156. Lanza, R.P., K.M. Borland, J.E. Staruk, M.C. Appel, B.A. Solomon, and W.L. Chick. 1992b. Transplantation of encapsulated canine islets into spontaneously diabetic BB/Wor rats without immunosuppression. Endocrinology 131:637-42.
157. Lanza, R.P. and W.L. Chick. eds. 1994a. Procurement of Pancreatic Islets. Vol. 1. Boulder, CO: R.G. Landes.
158. Lanza, R.P. and W.L. Chick. eds. 1994b. Immunoisolation of Pancreatic Islets. Vol. 2. Boulder, CO: R.G. Landes.
159. Lanza, R.P. and W.L. Chick. eds. 1994c. Immunomodulation of Pancreatic Islets. Vol. 3. Boulder, CO: R.G. Landes.
160. Lanza, R.P., W.M. Kuhtreiber, and W.L. Chick. 1995. Encapsulation technologies. Tiss. Eng. 1:181-96.
161. Lanza, R.P., A.P. Monaco, S.J. Sullivan, and W.L. Chick. 1992d. The hybrid artificial pancreas: Diffusion and vascular devices. Pancreatic Islet Cell Transplantation, ed. C. Ricordi, Chapter 22. Boulder, CO: R.G. Landes.
162. Lanza, R.P., S.J. Sullivan, and W.L. Chick. 1992. Islet transplantation with immunoisolation. Diabetes 41:1503-10.
163. Lauffenburger, D.A. and J.J. Linderman. 1993. Receptors, 73-78. New York: Oxford University Press.
164. Lavin, A., C. Sung, A.L. Klibanov, and R. Langer. 1985. A potential treatment for neonatal jaundice. Science 230:543-45.
165. Leach, J.B., K.A. Bivens, C.W. Patrick Jr., and C.E. Schmidt. 2003. Photocrosslinked hyaluronic acid hydrogels: Natural, biodegradable tissue engineering scaffolds. Biotechnol. Bioeng. 82:579-89.
166. Lee, C-J. and Y-L. Chang. 1988. Theoretical evaluation of the performance characteristics of a combined hemodialysis/hemoperfusion system-I. Single pass flow. Can. J. Chem. Eng. 66:263-70.
167. Lee, C-J., S-T. Hsu, and S-C. Hu. 1989. A one compartment single pore model for extracorporeal hemoperfusion. Comput. Biol. Med. 19:83-94.
168. Lee, W., V. Lee, S. Polio, P. Keegan, J.-H. Lee, K. Fischer, J.-K. Park, and S.-S. Yoo. 2010. On-demand three-dimensional freeform fabrication of multi-layered hydrogel scaffold with fluidic channels. Biotechnol. Bioeng. 105:1178-86.
169. Legallais, C., B. David, and E. Dore. 2001. Bioartificial livers (BAL): Current technological aspects and future developments. J. Membr. Sci. 181:81-95.
170. Lepeintre, J., H. Briandet, F. Moussy, D. Chicheportiche, S. Darquy, J. Rouchette, P. Imbaud, J.J. Duron, and G. Reach. 1990. Ex vivo evaluation in normal dogs of insulin released by a bioartificial pancreas containing isolated rat islets of Langerhans. Artif. Org. 14:20-27.
171. Levick, J.R. 1991. An Introduction to Cardiovascular Physiology. Boston, MA: Butterworths & Co.
172. Le Visage, C., S-H. Yang, L. Kadakia, A.N. Sieber, J.P. Kostuik, and K.W. Leong. 2006. Small intestinal submucosa as a potential bioscaffold for intervertebral disc regeneration. Spine 31:2423-30.
173. Lewis, R. 1997. New directions in research on blood substitutes. Genetic Eng. News 17:1.
174. Li, Z., T. Yipintsoi, and J.B. Bassingthwaighte. 1997. Nonlinear model for capillary-tissue oxygen transport and metabolism. Ann. Biomed. Eng. 25:604-19.
175. Lifson, N., K.G. Kramlinger, R.R. Mayrand, and E.J. Lender. 1980. Blood flow to the rabbit pancreas with special reference to the islets of Langerhans. Gastroenterology 79:466-73.
176. Liu, H., F.A. Ofosu, and P.L. Chang. 1993. Expression of human factor IX by microencapsulated recombinant fibroblasts. Hum. Gene Ther. 4:291-301.
177. Long, M.W. 1995. Tissue microenvironments. In The Biomedical Engineering Handbook, ed. J.D. Bronzino, 1692-1709. Boca Raton, FL: CRC Press.
178. Lu, L. and A.G. Mikos. 1996. The importance of new processing techniques in tissue engineering. MRS Bull. 21:28-32.
179. Lum, Z-P., I.T. Tai, M. Krestow, J. Norton, I. Vacek, and A.M. Sun. 1991. Prolonged reversal of diabetic state in NOD mice by xenografts of microencapsulated rat islets. Diabetes 40:1511-16.
180. Lysaght, M.J. and P.C. Farrell. 1989. Membrane phenomena and mass transfer kinetics in peritoneal dialysis. J. Mem. Sci. 44:5-33.
181. Lysaght, M.J. and J. Moran. 1995. Peritoneal dialysis equipment. In The Biomedical Engineering Handbook, ed. J.D. Bronzino, 1923-35. Boca Raton, FL: CRC Press.
182. Ma, P.X. and J-W. Choi. 2001. Biodegradable polymer scaffolds with well-defined interconnected spherical pore network. Tiss. Eng. 7:23-33.
183. Maki, T., J.P.A. Lodge, M. Carretta, H. Ohzato, K.M. Borland, S.J. Sullivan, and J. Staruk. 1993. Treatment of severe diabetes mellitus for more than one year using a vascularized hybrid artificial pancreas. Transplantation 55:713-18.
184. Maki, T., I. Otsu, J.J. O’Neil, K. Dunleavy, C.J.P. Mullon, B.A. Solomon, and A.P. Monaco. 1996. Treatment of diabetes by xenogeneic islets without immunosuppression. Diabetes 45:342-47.
185. Maki, T., C.S. Ubhi, H. Sanchez-Farpon, S.J. Sullivan, K. Borland, T.E. Muller, B.A. Solomon, W.L. Chick, and A.P. Monaco. 1991. Successful treatment of diabetes with the biohybrid artificial pancreas in dogs. Transplantation 51:43-51.
186. Makarewicz, A.J., L.F. Mockros, and R.W. Anderson. 1993. A pumping intravascular lung with active mixing. ASAIO J. 39:M466-69.
187. Malda, J., J. Rouwkema, D.E. Martens, E.P. le Comte, F.K. Kooy, J. Tramper, C.A. van Blitterswijk, and J. Riesle. 2004. Oxygen gradients in tissue engineered PEGT/PBT cartilaginous constructs: Measurement and modeling. Biotechnol. Bioeng. 86:9-18.
188. Mann, G.E., L.H. Smaje, and D.L. Yudilevich. 1979. Permeability of the fenestrated capillaries in the cat submandibular gland to lipid-insoluble molecules. J. Physiol. 297:335-54.
189. Marchant, R.E. and I-W. Wang. 1994. Physical and chemical aspects of biomaterials used in humans. In Implantation Biology, ed. R.S. Greco, 13-38. Boca Raton, FL: CRC Press.
190. Margiotta, M.S., L.D. Benton, and R.S. Greco. 1994. Integrins, adhesion molecules, and biomaterials. In Implantation Biology, ed. R.S. Greco, 149-63. Boca Raton, FL: CRC Press.
191. Martin, Y. and P. Vermette. 2005. Bioreactors for tissue mass culture: Design, characterization, and recent advances. Biomaterials 26:7481-7503.
192. Mathes, S.H., L. Wohlend, L. Uebersax, R. von Mentlen, D.S. Thoma, R.E. Jung, C. Gorlach, and U. Graf-Hausner. 2010. A bioreactor test system to mimic the biological and mechanical environment of oral soft tissues and to evaluate substitutes for connective tissue grafts. Biotechnol. Bioeng. 107:1029-39.
193. Matthew, H.W., S.O. Salley, W.D. Peterson, and M.D. Klein. 1993. Complex coacervate microcapsules for mammalian cell culture and artificial organ development. Biotechnol. Prog. 9:510-19.
194. Maxwell, J.C. 1873. A Treatise on Electricity and Magnetism. Vol. 1. Oxford: Clarendon Press.
195. Mazzei, D., M.A. Guzzardi, S. Giusti, and A. Ahluwalia. 2010. A low shear stress modular bioreactor for connected cell culture under high flow rates. Biotechnol. Bioeng. 106:127-37.
196. McCabe, W.L., J.C. Smith, and P. Harriott. 1985. Unit Operations of Chemical Engineering. 4th ed. New York: McGraw-Hill.
197. McNabb, M.E., R.V. Ebert, and K. McCusker. 1982. Plasma nicotine levels produced by chewing nicotine gum. JAMA 248:865-68.
198. Mehta, K. and J.J. Linderman. 2006. Model-based analysis and design of a microchannel reactor for tissue engineering. Biotechnol. Bioeng. 94:596-609.
199. Merrill, E.W., A.M. Benis, E.R. Gilliland, T.K. Sherwood, and E.W. Salzman. 1965. Pressure flow relations of human blood in hollow fibers at low flow rates. J. Appl. Physiol. 20:954-67.
200. Mikos, A.G., M.G. Papadaki, S. Kouvroukoglou, S.L. Ishaug, and R.C. Thomson. 1994. Mini-review: Islet transplantation to create a bioartificial pancreas. Biotechnol. Bioeng. 43:673-77.
201. Mikos, A.G., G. Sarakinos, M.D. Lyman, D.E. Ingber, J.P. Vacanti, and R. Langer. 1993. Pevascularization of porous biodegradable polymers. Biotechnol. Bioeng. 42:716-23.
202. Mirhashemi, S., K. Messmer, and M. Intaglietta. 1987. Tissue perfusion during normovolemic hemodilution investigated by a hydraulic model of the cardiovascular system. Int. J. Microcirc. Clin. Exp. 6:123-36.
203. Mitragotri, S. 2003. Modeling skin permeability to hydrophilic and hydrophobic solutes based on four permeation pathways. J. Control. Release 86:69-92.
204. Mooney, D.J., C. Breuer, K. McNamara, J.P. Vacanti, and R. Langer. 1995a. Fabricating tubular devices from polymers of lactic and glycolic acid for tissue engineering. Tiss. Eng. 1:107-17.
205. Mooney, D.J., P.M. Kaufmann, K. Sano, S.P. Schwendeman, K. Majahod, B. Schloo, J.P. Vacanti, and R. Langer. 1996. Localized delivery of epidermal growth factor improves the survival of transplanted hepatocytes. Biotechnol. Bioeng. 50:422-29.
206. Mooney, D.J., G. Organ, J.P. Vacanti, and R. Langer. 1994. Design and fabrication of biodegradable polymer devices to engineer tubular tissues. Cell Transplant. 3:203-10.
207. Mooney, D.J., S. Park, P.M. Kaufmann, K. Sano, K. McNamara, J.P. Vacanti, and R. Langer. 1995b. Biodegradable sponges for hepatocyte transplantation. J. Biomed. Mat. Res. 29:959-65.
208. Morgan, J.R., R.G. Tompkins, and M.L. Yarmush. 1994. Genetic engineering and therapeutics. In Implantation Biology, ed. R.S. Greco, 387-400. Boca Raton, FL: CRC Press.
209. Morgan, J.R. and M.L. Yarmush. 1997. Bioengineered skin substitutes. Sci. Med. 4:6-15.
210. Moussy, F., J Rouchette, G. Reach, R. Cannon, and M.Y. Jaffrin. 1989. In vitro evaluation of a bioartificial pancreas under various hemodynamic conditions. Artif. Org. 13:109-15.
211. Nagase, K., F. Kohori, and K. Sakai. 2005. Oxygen transfer of a membrane oxygenator composed of crossed and parallel hollow fibers. Biochem. Eng. J. 24:105-13.
212. Nam, J., Y. Huang, S. Agarwal, and J. Lannutti. 2007. Improved cellular infiltration in electrospun fiber via engineered porosity. Tiss. Eng. 13:2249-57.
213. Nam, J., Y. Huang, S. Agarwal, and J. Lannutti. 2008. Materials selection and residual solvent retention in biodegradable electrospun fibers. J. Appl. Polym. Sci. 107:1547-54.
214. Nam, J., B. Rath, T.J. Knobloch, J.J. Lannutti, and S. Agarwal. 2009. Novel electrospun scaffolds for the molecular analysis of chondrocytes under dynamic compression. Tiss. Eng. 15:513-23.
215. Naughton, G.K., W.R. Tolbert, and T.M. Grillot. 1995. Emerging developments in tissue engineering and cell technology. Tiss. Eng. 1:211-19.
216. Niro, R., J.P. Byers, R.L. Fournier, and K. Bachmann. 2003. Application of a convective-dispersion model to predict in vivo hepatic clearance from in vitro measurements using cryopreserved human hepatocytes. Curr. Drug Metab. 4:357-69.
217. Nomura, N., M. Schihiri, R. Kawamori, Y. Yamasaki, N. Iwama, and H. Abe. 1984. A mathematical insulin secretion model and its validation in isolated rat pancreatic islets perfusion. Comput. Biomed. Res. 17:570-79.
218. Nose, Y. 2001. Historical perspectives of hybrid hepatic assist devices. Ann. NY Acad. Sci. 944:18-34.
219. Notari, R.E. 1987. Biopharmaceutics and Clinical Pharmacokinetics. 4th ed. New York: Marcel Dekker.
220. Notkins, A.L. 1979. The causes of diabetes. Sci. Am. 241:62-73.
221. Nugent, L.J. and R.K. Jain. 1984a. Extravascular diffusion in normal and neoplastic tissues. Cancer Res. 44:238-44.
222. Nugent, L.J. and R.K. Jain. 1984b. Pore and fiber-matrix models for diffusive transport in normal and neoplastic tissues. Microvasc. Res. 28:270-74.
223. Nyberg, S.L., H.J. Mann, R.P. Remmel, W-S. Hu, and F.B. Cerra. 1993a. Pharmacokinetic analysis verifies P450 function during in vitro and in vivo application of a bioartificial liver. ASAIO J. 39:M252-56.
224. Nyberg, S.L., J.L. Platt, K. Shirabe, W.D. Payne, W-S. Hu, and F.B. Cerra. 1992. Immunoprotection of xenocytes in a hollow fiber bioartificial liver. ASAIO J. 38: M463-67.
225. Nyberg, S.L., R.A. Shatford, M.V. Peshwa, J.G. White, F.B. Cerra, and W-S. Hu. 1993b. Evaluation of a hepatocyte entrapment hollow fiber bioreactor: A potential bioartificial liver. Biotechnol. Bioeng. 41:194-203.
226. Obradovic, B., J.H. Meldon, L.E. Freed, and G. Vunjak-Novakovic. 2000. Glycosaminoglycan deposition in engineered cartilage: Experiments and mathematical model. AIChE J. 46:1860-71.
227. Oerther, S., H. LeGall, E. Payan, F. Lapicque, N. Presle, P. Hubert, J. Dexheimer, P. Netter, and F. Lapicque. 1999. Hyaluronate-alginate gel as a novel biomaterial: Mechanical properties and formation mechanism. Biotechnol. Bioeng. 63:206-15.
228. Ogston, A.G. 1958. The spaces in a uniform random suspension of fibers. Trans. Faraday Soc. 54:1754-57.
229. Oie, S. and T.N. Tozer. 1979. Effect of altered plasma protein binding on apparent volume of distribution. J. Pharm. Sci. 68:1203-5.
230. Ojcius, D.M., C-C. Liu, and J.D. Young. 1998. Pore-forming proteins. Sci. Med. 5:44-53.
231. Owen, D.H., J.J. Peters, and D.F. Katz. 2000. Rheological properties of contraceptive gels. Contraception 62:321-26.
232. Pachence, J.M. and J. Kohn. 1997. Biodegradable polymers for tissue engineering. In Principles of Tissue Engineering, ed. R.P. Lanza, R. Langer, and W.L. Chick, 273-93. Austin, TX: R.G. Landes.
233. Palsson, B.O. and S. Bhatia. 2004. Tissue Engineering. Upper Saddle River, NJ: Pearson Prentice Hall.
234. Panchagnula, R. 1997. Transdermal delivery of drugs. Indian J. Pharmacol. 29:140-56.
235. Park, J.H., B.G. Chung, W.G. Lee, J. Kim, M.D. Brigham, J. Shim, S. Lee, et al. 2010. Microporous cell-laden hydrogels for engineered tissue constructs. Biotechnol. Bioeng. 106:138-48.
236. Parsons-Wingerter, P. and E.H. Sage. 1997. Regulation of cell behavior by extracellular proteins. In Principles of Tissue Engineering, ed. R.P. Lanza, R. Langer, and W.L. Chick, 111-31. Austin, TX: R.G. Landes.
237. Pathak, C.P., A.S. Sawhney, and J.A. Hubbell. 1992. Rapid photopolymerization of immunoprotective gels in contact with cells and tissues. J. Am. Chem. Soc. 114:8311-12.
238. Patzer, J.F. 2001. Advances in bioartificial liver assist devices. Ann. NY Acad. Sci. 944:320-33.
239. Perez, E.P., E.W. Merrill, D. Miller, and L.G. Cima. 1995. Corneal epithelial wound healing on bilayer composite hydrogels. Tiss. Eng. 1:263-77.
240. Petersen, E.F., R.G.S. Spencer, and E.W. McFarland. 2002. Microengineering neocartilage scaffolds. Biotechnol. Bioeng. 78:802-5.
241. Petley A., B. Macklin, A.G. Renwick, T.J. Wilkin. 1995. The pharmacokinetics of nicotinamide in humans and rodents. Diabetes. 44:152-155.
242. Petruzzo, P., L. Pibiri, M.A. DeGiudici, G. Basta, R. Calafiore, A. Falorni, P. Brunetti, and G. Brotzu. 1991. Xenotransplantation of microencapsulated pancreatic islets contained in a vascular prosthesis: Preliminary results. Transplant Int. 4:200-4.
243. Poling, B.E., J.M. Prausnitz, and J.P. O’Connell. 2001. The Properties of Gases and Liquids. 5th ed. New York: McGraw-Hill.
244. Potts, R.O. and R.H. Guy. 1992. Predicting skin permeability. Pharm. Res. 9:663-69.
245. Powers, M.J., K. Domansky, M.R. Kaazempur-Mofrad, A. Kalezi, A. Capitano, A. Upadhyaya, P. Kurzawski, et al. 2002. A microfabricated array bioreactor for perfused 3D liver culture. Biotechnol. Bioeng. 78:257-69.
246. Pratt, A.B., F.E. Weber, H.G. Schmoekel, R. Muller, and J.A. Hubbell. 2004. Synthetic extracellular matrices for in situ tissue engineering. Biotechnol. Bioeng. 86:27-36.
247. Prausnitz, J.M., R.N. Lichtenthaler, and E.G. de Azevedo. 1986. Molecular Thermodynamics of Fluid-Phase Equilibria. 2nd ed. Englewood Cliffs, NJ: Prentice-Hall.
248. Prausnitz, J.M. and F.H. Shair. 1961. A thermodynamic correlation of gas solubilities. AIChE J. 7:682.
249. Radisic, M., W. Deen, R. Langer, and G. Vunjak-Novakovic. 2005. Mathematical model of oxygen distribution in engineered cardiac tissue with parallel channel array perfused with culture medium containing oxygen carriers. Am. J. Physiol. Heart Circ. Physiol. 288:H1278-89.
250. Radisic, M., M. Euloth, L. Yang, R. Langer, L. Freed, and G. Vunjak-Novakovic. 2003. High density seeding of myocyte cells in cardiac tissue engineering. Biotechnol. Bioeng. 82:403-14.
251. Radisic, M., J. Malda, E. Epping, W. Geng, R. Langer, and G. Vunjak-Novakovic. 2006. Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue. Biotechnol. Bioeng. 93:332-42.
252. Radisic, M., L. Yang, J. Boublik, R.J. Cohen, R. Langer, L.E. Freed, and G. Vunjak-Novakovic. 2004. Medium perfusion enables engineering of compact and contractile cardiac tissue. Am. J. Physiol. Heart Circ. Physiol. 286:H507-16.
253. Ramachandran, P.A. and R.A. Mashelkar. 1980. Lumped parameter model for hemodialyzer with application to simulation of patient-artificial kidney system. Med. Biol. Eng. Comput. 18:179-88.
254. Reid, R.C., J.M. Praunsnitz, and T.K. Sherwood. 1977. The Properties of Gases and Liquids. 3rd ed. New York: McGraw-Hill.
255. Renkin, E.M. 1954. Filtration, diffusion, and molecular sieving through porous cellulose membranes. J. Gen. Physiol. 38:225.
256. Renkin, E.M. 1977. Multiple pathways of capillary permeability. Circ. Res. 41:735-43.
257. Renkin, E.M. and F.E. Curry. 1979. Transport of water and solutes across capillary endothelium. In Membrane Transport in Biology, ed. G. Giebisch, and D.C. Tosteson, Vol. 4, Chapter 1. New York: Springer-Verlag.
258. Replogle, R.L., H.J. Meiselman, and E.W. Merrill. 1967. Clinical implications of blood rheology studies. Circulation 36:148-60.
259. Richardson, P.D. 1987. Artificial lungs and oxygenation devices. In Handbook of Bioengineering, ed. R. Skalak and S. Chien, Chapter 27. New York: McGraw-Hill Co.
260. Ricordi, C. (ed.) 1992. Pancreatic Islet Cell Transplantation. Boulder, CO: R.G. Landes Co.
261. Ricordi, C., P.E. Lacy, E.H. Finke, B.J. Olack, and D.W. Scharp. 1988. Automated method for isolation of human pancreatic islets. Diabetes 37:413-20.
262. Ricordi, C., C. Socci, A. Davalli, C. Staudacher, A. Vertova, P. Baro, M. Freschi, et al. 1990b. Swine islet isolation and transplantation. Horm. Metab. Res. 25:26-30.
263. Ricordi, C., C. Socci, A. Davalli, A. Vertova, P. Baro, I. Sassi, S. Braghi, N. Giuzzi, G. Pozza, and V. DiCarlo. 1990a. Application of the automated method to islet isolation in swine. Transplant. Proc. 22:784-85.
264. Riley, M.R., F.J. Muzzio, and H.M. Buettner. 1995c. The effect of structure on diffusion and reaction in immobilized cell systems. Chem. Eng. Sci. 50:3357-67.
265. Riley, M.R., F.J. Muzzio, H.M. Buettner, and S.C. Reyes. 1994. Monte Carlo calculation of effective diffusivities in two-and three-dimensional heterogeneous materials of variable structure. Phys. Rev. E. 49:3500-3.
266. Riley, M.R., F.J. Muzzio, H.M. Buettner, and S.C. Reyes. 1995a. Diffusion in heterogeneous media: Application to immobilized cell systems. AIChE J. 41:691-700.
267. Riley, M.R., F.J. Muzzio, H.M. Buettner, and S.C. Reyes. 1995b. Monte Carlo simulation of diffusion and reaction in two-dimensional cell structures. Biophys. J. 68:1716-26.
268. Riley, M.R., F.J. Muzzio, H.M. Buettner, and S.C. Reyes. 1996. A simple correlation for predicting effective diffusivities in immobilized cell systems. Biotechnol. Bioeng. 49:223-27.
269. Rosen, S.L. 1993. Fundamental Principles of Polymeric Materials. 2nd ed. New York: John Wiley.
270. Rosenberg, G. 1995. Artificial heart and circulatory assist devices. In The Biomedical Engineering Handbook, ed. J.D. Bronzino, 1839-46. Boca Raton, FL: CRC Press.
271. Rowland, M. and T.N. Tozer. 1995. Clinical Pharmacokinetics: Concepts and Applications. Philadelphia: Lippincott, Williams & Wilkins.
272. Rozga, J., E. Morsiani, E. LePage, A.D. Moscioni, T. Giorgio, and A.A. Demetriou. 1994. Isolated hepatocytes in a bioartificial liver: A single group view and experience. Biotechnol. Bioeng. 43:645-53.
273. Rozga, J., F. Williams, M-S. Ro, D.F. Neuzil, T.D. Giorgio, G. Backfisch, A.D. Moscioni, R Hakim, and A.A. Demetriou. 1993. Development of a bioartificial liver: Properties and function of a hollow fiber module inoculated with liver cells. Hepatology 17:258-65.
274. Rubin, E. and J.L. Farber. 1994. Pathology. 2nd ed. Philadelphia: J.B. Lippincott.
275. Saltzman, W.M. 1997. Cell interactions with polymers. In Principles of Tissue Engineering, ed. R.P. Lanza, R. Langer, and W.L. Chick, 225-46. Boulder, CO: R.G. Landes.
276. Sandler, S.I. 1989. Chemical Engineering Thermodynamics. 2nd ed. New York: John Wiley.
277. Sarver, J.G. 1994. Development of a tracer technique that utilizes a physiological pharmacokinetic model to quantitatively assess the change in mass transfer rates associated with vascular growth and the application of this technique to the evaluation of a novel bioartificial organoid. PhD dissertation. The University of Toledo.
278. Sarver, J.G. and R.L. Fournier. 1990. Numerical investigation of a novel spiral wound membrane sandwich design for an implantable bioartificial pancreas. Comput. Biol. Med. 20:105-19.
279. Sarver, J.G., R.L. Fournier, P.J. Goldblatt, T.L. Phares, S.E. Mertz, A.R. Baker, R.J. Mellon, J.M. Horner, and S.H. Selman. 1995. Tracer technique to measure in vivo chemical transport rates within an implantable cell transplantation device. Cell Transplant. 4:201-17.
280. Sauer, I.M., N. Obermeyer, D. Kardassis, T. Theruvath, and J.C. Gerlach. 2001. Development of a hybrid liver support system. Ann. NY Acad. Sci. 944:308-19.
281. Scharp, D.W., C.J. Swanson, B.J. Olack, P.P. Latta, O.D. Hegre, E.J. Doherty, F.T. Gentile, K.S. Flavin, M.F. Ansara, and P.E. Lacy. 1994. Protection of encapsulated human islets implanted without immunosuppression in patients with type I or type II diabetes and in nondiabetic control subjects. Diabetes 43:1167-70.
282. Schlichting, H. 1979. Boundary Layer Theory. New York: McGraw-Hill.
283. Schmelzer, E., K. Mutig, P. Schrade, S. Bachmann, J.C. Gerlach, and K. Zeilinger. 2009. Effect of human patient plasma ex vivo treatment of gene expression and progenitor cell activation of primary human liver cells in multi-compartment 3D perfusion bioreactors for extra-corporeal liver support. Biotechnol. Bioeng. 103:817-27.
284. Schrezenmeir, J., J. Kirchgessner, L. Gero, L.A. Kunz, J. Beyer, and W. Mueller-Klieser. 1994. Effect of microencapsulation on oxygen distribution in islets organs. Transplantation 57:1308-14.
285. Scott, M.D., K.L. Murad, F. Koumpouras, M. Talbot, and J.W. Eaton. 1997. Chemical camouflage of antigenic determinants: Stealth erythrocytes. Proc. Natl. Acad. Sci. USA 94:7566-71.
286. Secomb, T.W., R. Hsu, M.W. Dewhirst, B. Klitzman, and J.F. Gross. 1993. Analysis of oxygen transport to tumor tissue by microvascular networks. Int. J. Radiat. Oncol. Biol. Phys. 25:481-89.
287. Sefton, M.V., R.M. Dawson, R.L. Broughton, J. Blysniuk, and M.E. Sugamori. 1987. Microencapsulation of mammalian cells in a water insoluble polyacrylate by coextrusion and interfacial precipitation. Biotechnol. Bioeng. 29:1135-1143.
288. Selman, S.L., M. Kreimer-Birnbaum, J.E. Klaunig, P.J. Goldblatt, R.W. Keck, and S.L. Britton. 1984. Blood flow in transplantable bladder tumors treated with hematoporphyrin derivative and light. Cancer Res. 44:1924-27.
289. Shah, N. and A. Mehra. 1996. Modeling of oxygen uptake in perfluorocarbon emulsions. ASAIO J. 42:181-89.
290. Shaikh, F.M., T.P. O’Brien, A. Callanan, E.G. Kavanagh, P.E. Burke, P.A. Grace, and T.M. McGloughlin. 2010. New pulsatile hydrostatic pressure bioreactor for vascular tissue-engineered constructs. Artif. Org. 34:153-58.
291. Shaoting, W., Z. Fengbao, M. Tengxiang, and G. Hanqing. 1990. Investigation on patient-artificial kidney system using compartment models. Chem. Eng. Sci. 45:2943-48.
292. Shuler, M. and F. Kargi. 2001. Bioprocess Engineering: Basic Concepts. 2nd ed. Upper Saddle River, NJ: Prentice Hall.
293. Shiroki, R., T. Mohanakumar, and D.W. Scharp. 1995. Analysis of the serological and cellular sensitization induced by encapsulated human islets transplantation in type I and type II diabetes patients. Cell Transplant. 4:535-38.
294. Smith, B., J.G. Sarver, and R.L. Fournier. 1991. A comparison of islet transplantation and subcutaneous insulin injections for the treatment of diabetes mellitus. Comput. Biol. Med. 21:417-27.
295. Soon-Shiong, P. 1994. Encapsulated islet transplantation: Pathway to human clinical trials. In Immunoisolation of Pancreatic Islets, ed. R.P. Lanza and W.L. Chick, Chapter 6, Vol. 3. Boulder, CO: R.G. Landes.
296. Soon-Shiong, P., E. Feldman, R. Nelson, R. Heintz, N. Merideth, P. Sandford, T. Zheng, and J. Komtebedde. 1992b. Trans. Proc. 24:2946-47.
297. Soon-Shiong, P., E. Feldman, R. Nelson, R. Heintz, Q. Yao, O. Smidsrod, and P. Sandford. 1993. Longterm reversal of diabetes by the injection of immunoprotected islets. Proc. Natl. Acad. Sci. USA 90:5843-47.
298. Soon-Shiong, P., E. Feldman, R. Nelson, J. Komtebedde, O. Smidsrod, G. Skjak-Braek, T. Espevik, R. Heintz, and M. Lee. 1992a. Successful reversal of spontaneous diabetes in dogs by intraperitoneal microencapsulated islets. Transplantation 54:769-74.
299. Sorenson, J.T., C.K. Colton, R.S. Hillman, and J.S. Soeldner. 1982. Use of a pharmacokinetic model of glucose homeostasis for assessment of performance requirements for improved insulin therapies. Diabetes Care 5:148-57.
300. Spotnitz, H.M. 1987. Circulatory assist devices. In Handbook of Bioengineering, ed. R. Skalak and S. Chien, 38.1-38.18. New York: McGraw-Hill.
301. Staverman, A.J. 1948. Non-equilibrium thermodynamics of membrane processes. Trans. Faraday Soc. 48:176-85.
302. Storrs, R., R. Dorian, S.R. King, J. Lakey, and H. Rilo. 2001. Preclinical development of the islet sheet. Ann. NY Acad. Sci. 944:252-66.
303. Stryer, L. 1988. Biochemistry. New York: W.H. Freeman and Company.
304. Sturis, J., C. Knudsen, N.M. O’Meara, J.S. Thomsen, E. Mosekilde, E. Van Cauter, and K.S. Polonsky. 1995. Phase-locking regions in a forced model of slow insulin and glucose oscillations. In Dynamical Disease: Mathematical Analysis of Human Illness, ed. J. Belair, L. Glass, U. An der Heiden, and J. Milton. New York, NY: AIP Press.
305. Sturis, J., K.S. Polonsky, E. Mosekilde, and E. Van Cauter. 1991. Computer model for mechanisms underlying ultradian oscillations of insulin and glucose. Am. J. Physiol. 260:E801-E809.
306. Sugamori, M.E. and M.V. Sefton. 1989. Microencapsulation of pancreatic islets in a water insoluble polyacrylate. Trans. Am. Soc. Artif. Org. 35:791-99.
307. Sullivan, S.J., T. Maki, K.M. Borland, M.D. Mahoney, B.A. Solomon, T.E. Muller, A.P. Monaco, and W.L. Chick. 1991. Biohybrid artificial pancreas: Longterm implantation studies in diabetic, pancreatectomized dogs. Science 252:718-21.
308. Sun, A.M., W. Parisius, G.M. Healy, I. Vacek, and H.G. Macmorine. 1977. The use, in diabetic rats and monkeys, of artificial capillary units containing cultured islets of Langerhans. Diabetes 26:1136-39.
309. Sun, Y., X. Ma, D. Zhou, I. Vacek, and A.M. Sun. 1996. Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J. Clin. Invest. 98:1417-22.
310. Sung, C., A. Lavin, A.M. Klibanov, and R. Langer. 1986. An immobilized enzyme reactor for the detoxification of bilirubin. Biotechnol. Bioeng. 28:1531-39.
311. Sussman, N.L., M.G. Chong, T. Koussayer, D. He, T.A. Shang, H.H. Whisennand, and J.H. Kelly. 1992. Reversal of fulminant hepatic failure using an extracorporeal liver assist device. Hepatology 16:60-65.
312. Takeda, T., S. Murphy, S. Uyama, G.M. Organ, B.L. Schloo, and J.P. Vacanti. 1995. Hepatocyte transplantation in swine using prevascularized polyvinyl alcohol sponges. Tiss. Eng. 1:253-62.
313. Tatake, R.J., M.M. O’Neill, C.A. Kennedy, V.D. Reale, J.D. Runyan, K.-A.D. Monaco, K. Yu, W.R. Osborne, R.W. Barton, and R.D. Schneiderman. 2007. Glucose-regulated insulin production from genetically engineered human non-beta cells. Life Sci. 81:1346-54.
314. Teo, W.E. and S. Ramakrishna. 2006. A review on electrospinning design and nanofibre assemblies. Nanotechnology 17:R89-R106.
315. Thomas, L.C. 1992. Heat Transfer. New York: Prentice-Hall.
316. Thompson, J.A., K.D. Anderson, J.M. DiPietro, J.A. Zwiebel, M. Zametta, W.F. Anderson, and T. Maciag. 1988. Site-directed neovessel formation in vivo. Science 241:1349-52.
317. Thompson, J.A., C.C. Haudenschild, K.D. Anderson, J.M. DiPietro, W.F. Anderson, and T. Maciag. 1989. Heparin-binding growth factor 1 induces the formation of organoid neovascular structures in vivo. Proc. Natl. Acad. Sci. USA 86:7928-32.
318. Thomson, R.C., M.J. Yaszemski, and A.G. Mikos. 1997. Polymer scaffold processing. In Principles of Tissue Engineering, ed. R.P. Lanza, R. Langer, and W.L. Chick, 263-72. Austin, TX: R.G. Landes.
319. Tilles, A.W., H. Baskaaran, P. Roy, M.L. Yarmush, and M. Toner. 2001. Effects of oxygenation and flow on the viability and function of rat hepatocytes cocultured in a microchannel flat-plate bioreactor. Biotechnol. Bioeng. 74:379-89.
320. Tinoco, I., K. Sauer, J.C. Wang, and J.D. Puglisi. 2001. Physical Chemistry: Principles and Applications in Biological Sciences. 4th ed. New York: Prentice-Hall.
321. Tong, J. and J.L. Anderson. 1996. Partitioning and diffusion of proteins and linear polymers in polyacrylamide gels. Biophys. J. 70:1505-13.
322. Tozer, T.N. and M. Rowland. 2006. Introduction to Pharmacokinetics and Pharmacodynamics. Baltimore, MD: Lippincott, Williams & Wilkins.
323. Tsai, A.G., K.-E. Arfors, and M. Intaglietta. 1990. Analysis of oxygen transport to tissue during extreme hemodilution. Adv. Exp. Med. Biol. 277:881-87.
324. Tun, T., H. Hayashi, T. Aung, Y-J. Gu, R. Doi, H. Kaji, Y. Echigo, et al. 1996. A newly developed three layer agarose microcapsule for a promising biohybrid artificial pancreas: Rat to mouse xenotransplantation. Cell Transplant. 5:S59-S63.
325. Tyn, M.T., and T.W. Gusek. 1990. Prediction of diffusion coefficients of proteins. Biotechnol. Bioeng. 35:327-38.
326. Van Blitterswijk, C., P. Thomsen, J. Hubbel, and R. Cancedda. (ed.) 2008. Tissue Engineering. London: Elsevier.
327. Vaslef, S.N., L.F. Mockros, and R.W. Anderson. 1989. Development of an intravascular lung assist device. ASAIO Trans. 35:660-64.
328. Vaslef, S.N., L.F. Mockros, R.W. Anderson, and R.J. Leonard. 1994. Use of a mathematical model to predict oxygen transfer rates in hollow fiber membrane oxygenators. ASAIO J. 40:990-96.
329. Verma, R.K., D. Murali Krishna, and S. Garg. 2002. Formulation aspects in the development of osmotically controlled oral drug delivery systems. J. Control. Release 79:7-27.
330. Wake, M.C., C.W. Patrick Jr., and A.G. Mikos. 1994. Pore morphology effects on the fibrovascular tissue growth in porous polymer substrates. Cell Transplant. 3:339-43.
331. Warnock, W.L., D. Ellis, R.V. Rajotte, I. Dawidson, S. Baekkeskov, and J. Egebjerg. 1988. Studies of the isolation and viability of human islets of Langerhans. Transplantation 45:957-63.
332. Warnock, W.L., D.K. Ellis, M. Cattral, D. Untch, N.M. Kneteman, and R.V. Rajotte. 1989. Viable purified islets of Langerhans from collagenase perfused human pancreas. Diabetes 38:136-39.
333. Warnock, W.L. and R.V. Rajotte. 1988. Critical mass of purified islets that induce normoglycemia after implantation into dogs. Diabetes 37:467-70.
334. Welling, P.G. 1986. Pharmacokinetics: Processes and Mathematics, ACS monograph 185. Washington, DC: American Chemical Society.
335. Welsh, E.R. and D.A. Tirrell. 2000. Engineering the extracellular matrix: A novel approach to polymeric biomaterials. I. Control of the physical properties of artificial protein matrices designed to support adhesion of vascular endothelial cells. Biomacromolecules 1:23-30.
336. Wickramasinghe, S.R., J.D. Garcia, and B. Han. 2002a. Mass and momentum transfer in hollow fiber blood oxygenators. J. Membr. Sci. 208:247-56.
337. Wickramasinghe, S.R. and B. Han. 2005. Designing microporous hollow fibre blood oxygenators. Trans. IChemE, Part A. 83:256-67.
338. Wickramasinghe, S.R., B. Han, J.D. Garcia, and P. Specht. 2005. Microporous membrane blood oxygenators. AIChE J. 51:656-70.
339. Wickramasinghe, S.R., C.M. Kahr, and B. Han. 2002b. Mass transfer in blood oxygenators using blood analogue fluids. Biotechnol. Prog. 18:867-73.
340. Winslow, R.M. 1997. Blood substitutes. Sci. Med. 4:54-63.
341. Wright, J.C., S.T. Leonard, C.L. Stevenson, J.C. Beck, G. Chen, R.M. Jao, P.A. Johnson, J. Leonard, and R.J. Skowronski. 2001. An in vivo/in vitro comparison with a leuprolide somotic implant for the treatment of prostate cancer. J. Control. Release 75:1-10.
342. Yang, M-C. and E.L. Cussler. 1986. Designing hollow-fiber contactors. AIChE J. 32:1910-16.
343. Yang, M.B., J.P. Vacanti, and D.E. Ingber. 1994. Hollow fibers for hepatocyte encapsulation and transplantation: Studies of survival and function in rats. Cell Transplant. 3:373-85.
344. Yarmush, M.L., J.C.Y. Dunn, and R.G. Tompkins. 1992. Assessment of artificial liver support technology. Cell Transplant. 1:323-41.
345. Yildirim, E.D., R. Besunder, S. Guceri, F. Allen, and W. Sun. 2008. Fabrication and plasma treatment of 3D polycaprolactone tissue scaffolds for enhanced cellular function. Virtual Phys. Prototyping 3:199-207.
346. Yildirim, E.D., R. Besunder, D. Pappas, F. Allen, S. Guceri, and W. Sun. 2010. Accelerated differentiation of osteoblast cells on polycaprolactone scaffolds driven by a combined effect of protein coating and plasma modification. Biofabrication 2:1-12.
347. Zalzman, M., S. Gupta, R.K. Giri, I. Berkovich, B.S. Sappal, O. Karnieli, M.A. Zern, N. Fleischer, and S. Efrat. 2003. Reversal of hyperglycemia in mice by using human expandable insulin-producing cells differentiated from fetal liver progenitor cells. Proc. Natl. Acad. Sci. USA 100:7253-58.
348. Zekorn, T., U. Siebers, R.G. Bretzel, M. Renardy, H. Planck, P. Zschocke, and K. Federlin. 1990. Protection of islets of Langerhans from interleukin-1 toxicity by artificial membranes. Transplantation 50:391-94.
349. Zelman, A. 1987. The artificial kidney. In Handbook of Bioengineering, ed. R. Skalak and S. Chien, Chapter 39. New York: McGraw-Hill.
350. Zhao, F. and T. Ma. 2005. Perfusion bioreactor system for human mesenchymal stem cell tissue engineering: Dynamic cell seeding and construct development. Biotechnol. Bioeng. 91:482-93.
351. Zhmud, B.V., F. Tiberg, and K. Hallstensson. 2000. Dynamics of capillary rise. J. Col. Int. Sci. 228:263-69.
352. Zielinski, B.A., M.B. Goddard, and M.J. Lysaght. 1997. Immunoisolation. In Principles of Tissue Engineering, ed. R.P. Lanza, R. Langer, and W.L. Chick, 323-32. Austin, TX: R.G. Landes.
353. Zydney, A.L. 1995. Therapeutic apheresis and blood fractionation. In The Biomedical Engineering Handbook, ed. J.D. Bronzino, 1936-51. Boca Raton, FL: CRC Press.
354. Zydney, A.L. and C.K. Colton. 1986. A concentration polarization model for the filtrate flux in cross-flow microfiltration of particulate suspensions. Chem. Eng. Comm. 47:1-21.